InsiderTrades.com logo

GALT Insider Trading

Insider Ownership Percentage: 52.60%
Insider Buying (Last 12 Months): $18,660.00
Insider Selling (Last 12 Months): $3,557,419.44

Galectin Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Galectin Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Galectin Therapeutics Share Price & Price History

Current Price: $6.15
Price Change: ▼ Price Decrease of -0.32 (-4.95%)
As of 12/18/2025 04:59 PM ET

This chart shows the closing price history over time for GALT up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Galectin Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/16/2025Fund L.P. 10XMajor ShareholderSell30,681$6.66$204,335.465,614,457View SEC Filing Icon  
12/9/2025Harold H ShlevinDirectorSell16,790$6.27$105,273.3011,206View SEC Filing Icon  
12/8/2025Harold H ShlevinDirectorSell159,000$5.98$950,820.0011,206View SEC Filing Icon  
12/3/2025Fund L.P. 10XMajor ShareholderSell120,000$5.73$687,600.005,682,207View SEC Filing Icon  
12/2/2025Fund L.P. 10XMajor ShareholderSell30,000$5.47$164,100.005,802,207View SEC Filing Icon  
11/13/2025Khurram JamilInsiderSell121,117$5.47$662,509.994,479View SEC Filing Icon  
11/5/2025Joel LewisCEOSell200$6.00$1,200.00832,592View SEC Filing Icon  
11/4/2025Jack W CallicuttCFOSell28,629$6.07$173,778.037,614View SEC Filing Icon  
11/4/2025Joel LewisCEOSell14,420$6.07$87,529.40832,592View SEC Filing Icon  
11/3/2025Jack W CallicuttCFOSell3,810$6.01$22,898.107,614View SEC Filing Icon  
11/3/2025Joel LewisCEOSell1,300$6.01$7,813.00832,592View SEC Filing Icon  
10/22/2025Fund L.P. 10XMajor ShareholderSell50,000$4.94$247,000.005,872,207View SEC Filing Icon  
9/12/2025Jack W CallicuttCFOSell8,706$6.44$56,066.647,614View SEC Filing Icon  
9/12/2025Joel LewisCEOSell14,000$6.36$89,040.00832,592View SEC Filing Icon  
7/21/2025Kary EldredDirectorBuy1,000$2.92$2,920.0064,682View SEC Filing Icon  
12/30/2024Harold H ShlevinDirectorBuy6,500$1.16$7,540.0015,206View SEC Filing Icon  
12/24/2024Richard A. Zordani, Jr.DirectorBuy10,000$0.82$8,200.0042,083View SEC Filing Icon  
12/23/2024Jack W CallicuttCFOSell40,000$0.89$35,600.007,614View SEC Filing Icon  
12/23/2024Joel LewisCEOSell56,000$0.89$49,840.00897,012View SEC Filing Icon  
12/23/2024Khurram JamilInsiderSell13,654$0.88$12,015.5226,346View SEC Filing Icon  
10/23/2024Kary EldredDirectorBuy500$2.60$1,300.0050,213View SEC Filing Icon  
10/16/2024Kevin D. FreemanDirectorBuy5,000$2.70$13,500.0033,469View SEC Filing Icon  
8/23/2024Richard A. Zordani, Jr.DirectorBuy1,759$2.30$4,045.7032,083View SEC Filing Icon  
4/30/2024Richard A. Zordani, Jr.DirectorBuy1,000$3.52$3,520.001,000View SEC Filing Icon  
4/24/2024Joel LewisCEOBuy1,000$3.39$3,390.002,000View SEC Filing Icon  
4/22/2024James C CzirrMajor ShareholderSell21,323$3.06$65,248.385,925,884View SEC Filing Icon  
4/22/2024Kevin D. FreemanDirectorBuy2,500$2.98$7,450.0025,969View SEC Filing Icon  
1/16/2024Kary EldredDirectorBuy500$1.79$895.0049,313View SEC Filing Icon  
7/19/2023Kary EldredDirectorBuy1,598$1.79$2,860.4248,813View SEC Filing Icon  
2/21/2023Kary EldredDirectorBuy1,000$1.59$1,590.0047,215View SEC Filing Icon  
2/16/2023Joel LewisCEOBuy1,000$1.52$1,520.001,000View SEC Filing Icon  
1/25/2023Kary EldredDirectorBuy1,300$1.11$1,443.0046,215View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Galectin Therapeutics (NASDAQ:GALT)

11.68% of Galectin Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GALT by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Galectin Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/15/2025Hudson Bay Capital Management LP14,826$63K0.0%N/A0.023%Search for SEC Filing on Google Icon
11/17/2025Vivaldi Capital Management LP255,752$1.08M0.2%+48.3%0.397%Search for SEC Filing on Google Icon
11/17/2025Sig Brokerage LP15,717$67K0.0%-19.4%0.024%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd60,867$0.26M0.0%+290.9%0.094%Search for SEC Filing on Google Icon
11/17/2025Millennium Management LLC110,422$0.47M0.0%-23.6%0.171%Search for SEC Filing on Google Icon
11/17/2025Lido Advisors LLC36,327$0.15M0.0%N/A0.056%Search for SEC Filing on Google Icon
11/17/2025Bank of America Corp DE25,327$0.11M0.0%+129.4%0.039%Search for SEC Filing on Google Icon
11/14/2025Ancora Advisors LLC52,380$0.22M0.0%+302.9%0.081%Search for SEC Filing on Google Icon
11/14/2025Virtu Financial LLC38,968$0.17M0.0%N/A0.060%Search for SEC Filing on Google Icon
11/14/2025Two Sigma Investments LP16,647$70K0.0%N/A0.026%Search for SEC Filing on Google Icon
11/13/2025Jefferies Financial Group Inc.17,300$73K0.0%N/A0.027%Search for SEC Filing on Google Icon
11/7/2025GSA Capital Partners LLP87,094$0.37M0.0%N/A0.135%Search for SEC Filing on Google Icon
11/7/2025Vanguard Group Inc.2,247,967$9.52M0.0%+2.9%3.486%Search for SEC Filing on Google Icon
11/7/2025JPMorgan Chase & Co.15,470$66K0.0%+25.4%0.024%Search for SEC Filing on Google Icon
11/6/2025Stratos Wealth Partners LTD.30,050$0.13M0.0%-50.5%0.047%Search for SEC Filing on Google Icon
11/3/2025Archer Investment Corp11,000$47K0.0%N/A0.017%Search for SEC Filing on Google Icon
10/31/2025Sovran Advisors LLC157,405$0.67M0.1%-16.7%0.244%Search for SEC Filing on Google Icon
10/22/2025Geneos Wealth Management Inc.360,175$1.53M0.0%-14.9%0.562%Search for SEC Filing on Google Icon
10/21/2025Retirement Guys Formula LLC165,993$0.70M0.2%+4.0%0.259%Search for SEC Filing on Google Icon
10/15/2025Atwood & Palmer Inc.10,000$42K0.0%N/A0.016%Search for SEC Filing on Google Icon
9/4/2025Osaic Holdings Inc.1,265,384$2.67M0.0%+3.4%1.975%Search for SEC Filing on Google Icon
8/14/2025Jane Street Group LLC748,652$1.58M0.0%N/A1.183%Search for SEC Filing on Google Icon
8/14/2025Vivaldi Capital Management LP172,443$0.36M0.1%+210.0%0.272%Search for SEC Filing on Google Icon
8/13/2025Marshall Wace LLP30,400$64K0.0%N/A0.048%Search for SEC Filing on Google Icon
8/12/2025XTX Topco Ltd42,805$90K0.0%+226.6%0.068%Search for SEC Filing on Google Icon
8/12/2025JPMorgan Chase & Co.12,337$26K0.0%-27.3%0.019%Search for SEC Filing on Google Icon
8/11/2025Wealthspire Advisors LLC479,518$1.01M0.0%+20.4%0.758%Search for SEC Filing on Google Icon
8/8/2025Geode Capital Management LLC666,191$1.41M0.0%-21.9%1.053%Search for SEC Filing on Google Icon
7/29/2025Stratos Wealth Partners LTD.60,750$0.13M0.0%+17.8%0.096%Search for SEC Filing on Google Icon
7/18/2025Truist Financial Corp68,000$0.14M0.0%N/A0.107%Search for SEC Filing on Google Icon
7/15/2025Retirement Guys Formula LLC159,593$0.34M0.1%+2.7%0.252%Search for SEC Filing on Google Icon
7/10/2025Sovran Advisors LLC188,972$0.40M0.0%-5.4%0.299%Search for SEC Filing on Google Icon
5/21/2025Geneos Wealth Management Inc.423,235$0.52M0.0%+8.8%0.670%Search for SEC Filing on Google Icon
5/13/2025HighTower Advisors LLC77,375$94K0.0%+244.1%0.122%Search for SEC Filing on Google Icon
5/12/2025Nuveen LLC27,623$34K0.0%N/A0.044%Search for SEC Filing on Google Icon
5/9/2025Charles Schwab Investment Management Inc.22,913$28K0.0%-64.8%0.036%Search for SEC Filing on Google Icon
5/9/2025Atria Wealth Solutions Inc.186,000$0.23M0.0%-10.2%0.294%Search for SEC Filing on Google Icon
5/6/2025Y Intercept Hong Kong Ltd235,192$0.29M0.0%N/A0.372%Search for SEC Filing on Google Icon
4/25/2025Sovran Advisors LLC199,830$0.24M0.0%+7.4%0.316%Search for SEC Filing on Google Icon
4/16/2025Wealth Enhancement Advisory Services LLC36,141$44K0.0%-29.8%0.057%Search for SEC Filing on Google Icon
3/17/2025Wealth Enhancement Advisory Services LLC51,510$66K0.0%+46.8%0.082%Search for SEC Filing on Google Icon
2/17/2025Vivaldi Capital Management LP45,628$56K0.0%+89.9%0.073%Search for SEC Filing on Google Icon
2/17/2025Bank of America Corp DE38,358$49K0.0%+101.4%0.061%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp244,274$0.32M0.0%+4.3%0.389%Search for SEC Filing on Google Icon
2/14/2025Two Sigma Securities LLC28,571$37K0.0%N/A0.046%Search for SEC Filing on Google Icon
2/13/2025Barclays PLC54,634$71K0.0%+91.1%0.087%Search for SEC Filing on Google Icon
2/12/2025Geode Capital Management LLC870,589$1.12M0.0%+0.9%1.387%Search for SEC Filing on Google Icon
2/12/2025JPMorgan Chase & Co.59,693$77K0.0%+94.9%0.095%Search for SEC Filing on Google Icon
2/11/2025LPL Financial LLC138,928$0.18M0.0%+69.6%0.221%Search for SEC Filing on Google Icon
2/10/2025Commonwealth Equity Services LLC134,518$0.17M0.0%-72.2%0.214%Search for SEC Filing on Google Icon
2/7/2025HighTower Advisors LLC22,486$29K0.0%N/A0.036%Search for SEC Filing on Google Icon
2/7/2025Inspire Advisors LLC21,095$27K0.0%+86.3%0.034%Search for SEC Filing on Google Icon
2/7/2025PNC Financial Services Group Inc.20,000$26K0.0%N/A0.032%Search for SEC Filing on Google Icon
2/4/2025Bank of New York Mellon Corp50,826$66K0.0%+19.0%0.081%Search for SEC Filing on Google Icon
1/31/2025D.A. Davidson & CO.19,000$25K0.0%-38.3%0.030%Search for SEC Filing on Google Icon
1/31/2025Sanctuary Advisors LLC58,413$73K0.0%-26.2%0.093%Search for SEC Filing on Google Icon
1/29/2025Retirement Guys Formula LLC155,343$0.20M0.1%+143.4%0.248%Search for SEC Filing on Google Icon
1/29/2025Sovran Advisors LLC186,014$0.24M0.0%N/A0.296%Search for SEC Filing on Google Icon
1/27/2025Stratos Wealth Partners LTD.51,550$66K0.0%+27.4%0.082%Search for SEC Filing on Google Icon
1/21/2025Geneos Wealth Management Inc.388,935$0.50M0.0%+10.2%0.620%Search for SEC Filing on Google Icon
1/17/2025Traynor Capital Management Inc.55,670$72K0.0%+29.9%0.089%Search for SEC Filing on Google Icon
1/10/2025Wealth Enhancement Advisory Services LLC51,369$66K0.0%+46.4%0.082%Search for SEC Filing on Google Icon
12/26/2024JPMorgan Chase & Co.30,628$84K0.0%+161.3%0.049%Search for SEC Filing on Google Icon
11/25/2024Sanctuary Advisors LLC79,113$0.22M0.0%-21.4%0.126%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC28,587$79K0.0%+309.0%0.046%Search for SEC Filing on Google Icon
11/18/2024Soltis Investment Advisors LLC140,750$0.39M0.0%N/A0.226%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC862,542$2.37M0.0%+2.5%1.385%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC28,587$79K0.0%+309.0%0.046%Search for SEC Filing on Google Icon
11/15/2024Kovitz Investment Group Partners LLC42,540$0.12M0.0%N/A0.068%Search for SEC Filing on Google Icon
11/15/2024State Street Corp251,014$0.69M0.0%+9.3%0.403%Search for SEC Filing on Google Icon
11/13/2024D.A. Davidson & CO.30,771$85K0.0%-36.9%0.049%Search for SEC Filing on Google Icon
10/28/2024Gladstone Institutional Advisory LLC21,750$60K0.0%N/A0.035%Search for SEC Filing on Google Icon
10/21/2024Retirement Guys Formula LLC63,817$0.18M0.1%+55.1%0.103%Search for SEC Filing on Google Icon
9/5/2024Sanctuary Advisors LLC100,658$0.23M0.0%N/A0.162%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC84,074$0.19M0.0%+75.4%0.135%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP18,825$43K0.0%N/A0.030%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers19,275$44K0.0%N/A0.031%Search for SEC Filing on Google Icon
7/31/2024Commonwealth Equity Services LLC483,351$1.09M0.0%+317.6%0.778%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp64,423$0.15M0.0%N/A0.104%Search for SEC Filing on Google Icon
7/24/2024Traynor Capital Management Inc.42,871$97K0.0%+23.5%0.069%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,979,891$4.73M0.0%+2.0%3.198%Search for SEC Filing on Google Icon
5/7/2024Wealthspire Advisors LLC398,374$0.95M0.0%+116.7%0.644%Search for SEC Filing on Google Icon
5/4/2024Geneos Wealth Management Inc.408,850$0.98M0.0%-0.9%0.660%Search for SEC Filing on Google Icon
4/19/2024Retirement Guys Formula LLC33,732$81K0.0%+56.9%0.054%Search for SEC Filing on Google Icon
2/6/2024Solutions 4 Wealth Ltd36,085$60K0.2%N/A0.058%Search for SEC Filing on Google Icon
2/2/2024Atria Wealth Solutions Inc.249,800$0.42M0.0%-3.8%0.404%Search for SEC Filing on Google Icon
2/1/2024Cutter & CO Brokerage Inc.117,488$0.20M0.1%-9.3%0.190%Search for SEC Filing on Google Icon
1/22/2024Retirement Guys Formula LLC21,500$36K0.0%+87.0%0.035%Search for SEC Filing on Google Icon
1/9/2024Beacon Capital Management LLC23,905$40K0.0%+89.6%0.039%Search for SEC Filing on Google Icon
11/8/2023D.A. Davidson & CO.37,825$73K0.0%+15.2%0.061%Search for SEC Filing on Google Icon
10/16/2023Traynor Capital Management Inc.34,707$67K0.0%N/A0.056%Search for SEC Filing on Google Icon
10/11/2023AE Wealth Management LLC26,841$52K0.0%+72.7%0.043%Search for SEC Filing on Google Icon
8/3/2023Atria Wealth Solutions Inc.260,800$0.38M0.0%-3.7%0.439%Search for SEC Filing on Google Icon
7/25/2023Summit Trail Advisors LLC20,000$29K0.0%N/A0.034%Search for SEC Filing on Google Icon
7/13/2023Cambridge Investment Research Advisors Inc.134,332$0.19M0.0%-5.7%0.226%Search for SEC Filing on Google Icon
5/12/2023Independent Advisor Alliance36,100$76K0.0%N/A0.061%Search for SEC Filing on Google Icon
5/9/2023Wealthspire Advisors LLC183,862$0.39M0.0%N/A0.309%Search for SEC Filing on Google Icon
5/9/2023Wedbush Securities Inc.15,498$33K0.0%-36.7%0.026%Search for SEC Filing on Google Icon
4/25/2023Geneos Wealth Management Inc.427,400$0.90M0.1%-1.7%0.719%Search for SEC Filing on Google Icon
2/7/2023Commonwealth Equity Services LLC101,522$0.11M0.0%+165.6%0.170%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Galectin Therapeutics logo
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. Its lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, that is in Phase 2b/3 clinical trial, to prevent esophageal varices in patient with non-alcoholic steatohepatitis (NASH) cirrhosis; and Phase 2 clinical trial for the treatment of liver fibrosis, as well as severe skin disease, and melanoma and head and neck squamous cell carcinoma. The company, through its Galectin Sciences, LLC, which is a collaborative joint venture co-owned by SBH Sciences, Inc., to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics, Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Read More on Galectin Therapeutics

Today's Range

Now: $6.15
Low: $6.15
High: $6.95

50 Day Range

MA: $5.54
Low: $4.72
High: $6.51

52 Week Range

Now: $6.15
Low: $0.73
High: $7.13

Volume

429,204 shs

Average Volume

401,294 shs

Market Capitalization

$396.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Galectin Therapeutics?

Galectin Therapeutics' top insider investors include:
  1. James C Czirr (Major Shareholder)
  2. Fund LP 10X (Major Shareholder)
  3. Joel Lewis (CEO)
  4. Kary Eldred (Director)
  5. Richard A Jr Zordani (Director)
  6. Kevin D Freeman (Director)
  7. Khurram Jamil (Insider)
  8. Harold H Shlevin (Director)
  9. Jack W Callicutt (CFO)
Learn More about top insider investors at Galectin Therapeutics.

Who are the major institutional investors of Galectin Therapeutics?

Galectin Therapeutics' top institutional shareholders include:
  1. Vanguard Group Inc. — 3.49%
  2. Geneos Wealth Management Inc. — 0.56%
  3. Vivaldi Capital Management LP — 0.40%
  4. Retirement Guys Formula LLC — 0.26%
  5. Sovran Advisors LLC — 0.24%
  6. Millennium Management LLC — 0.17%
Learn More about top institutional investors of Galectin Therapeutics stock.

Which major investors are selling Galectin Therapeutics stock?

In the last quarter, GALT stock was sold by these institutional investors:
  1. Geneos Wealth Management Inc.
  2. Group One Trading LLC
  3. Citadel Advisors LLC
  4. Millennium Management LLC
  5. Sovran Advisors LLC
  6. Stratos Wealth Partners LTD.
  7. Sig Brokerage LP
Within the last year, company insiders that have sold Galectin Therapeutics company stock include:
  1. James C Czirr (Major Shareholder)
  2. Fund LP 10X (Major Shareholder)
  3. Joel Lewis (CEO)
  4. Kary Eldred (Director)
  5. Richard A Jr Zordani (Director)
Learn More investors selling Galectin Therapeutics stock.

Which major investors are buying Galectin Therapeutics stock?

In the last quarter, GALT stock was purchased by institutional investors including:
  1. GSA Capital Partners LLP
  2. Vivaldi Capital Management LP
  3. Vanguard Group Inc.
  4. Qube Research & Technologies Ltd
  5. Ancora Advisors LLC
  6. Virtu Financial LLC
  7. Lido Advisors LLC
  8. Susquehanna International Group LLP
In the previous year, these company insiders have bought Galectin Therapeutics stock:
  1. James C Czirr (Major Shareholder)
  2. Fund LP 10X (Major Shareholder)
  3. Joel Lewis (CEO)
  4. Kary Eldred (Director)
  5. Richard A Jr Zordani (Director)
Learn More investors buying Galectin Therapeutics stock.